Effect of Fludrocortisone on Adrenoceptors and Free Intracellular Calcium in Man
暂无分享,去创建一个
A. Kribben | H. Haller | T. Philipp | S. Harwig | E. Fritschka | A. Distler | T. Lenz | H. Thiede | M. Luedersdorf
[1] M. Kuramochi,et al. Effect of dietary sodium on platelet alpha 2-adrenergic receptors in essential hypertension. , 1985, Hypertension.
[2] R. Webb,et al. Cerebral Intraventricular 6-Hydroxydopamine Prevents Vascular Changes in the Mineralocorticoid Hypertensive Rat 1 , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[3] J. Laragh,et al. Calcium metabolism and parathyroid function in primary aldosteronism. , 1985, The American journal of medicine.
[4] L. Krakoff,et al. Reduced Sympathetic Neuronal Uptake (Uptake1) in a Genetic Model of Desoxycorticosterone-NaCl Hypertension 1 , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[5] H. Motulsky,et al. A hypothesis linking intracellular sodium, membrane receptors, and hypertension. , 1984, Life sciences.
[6] R. Tsien,et al. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca‐independent activation for shape‐change and secretion , 1982, FEBS letters.
[7] G. Wright,et al. Concentrations of ionic and total calcium in plasma of four models of hypertension. , 1982, The American journal of physiology.
[8] R Y Tsien,et al. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator , 1982, The Journal of cell biology.
[9] J. Mooney,et al. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes. , 1982, Molecular pharmacology.
[10] A. W. Jones,et al. Aldosterone Infusion into the Rat and Dose‐Dependent Changes in Blood Pressure and Arterial Ionic Transport , 1982, Hypertension.
[11] A. J. Man in 't Veld,et al. Time-course of vascular resistance changes in mineralocorticoid hypertension of man. , 1981, Clinical science.
[12] T. Brock,et al. Preand Postcapillary Vascular Responses to Sympathetic Nerve Stimulation in DOCA‐Hypertensive Dogs , 1981, Hypertension.
[13] S. Yamada,et al. Alterations in central and peripheral adrenergic receptors in deoxycorticosterone/salt hypertensive rats. , 1980, Life sciences.
[14] C. Johnston,et al. Reduced vascular beta-adrenergic receptors in deoxycorticosterone-salt hypertensive rats. , 1980, Biochemical pharmacology.
[15] S. Oparil,et al. Importance of Renal Sympathetic Tone in the Development of DOCA‐Salt Hypertension in the Rat , 1980, Hypertension.
[16] C. Johnston,et al. Decreased cardiac beta-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. , 1979, Circulation research.
[17] S. Friedman,et al. Evidence for enhanced Na transport in hypertension induced by DOCA in the rat. , 1978, Canadian journal of physiology and pharmacology.
[18] H. W. Overbeck,et al. Abnormal Ion and Water Composition of Veins and Normotensive Arteries in Coarctation Hypertension in Rats , 1976, Circulation research.
[19] J. Reid,et al. Central and Peripheral Adrenergic Mechanisms in the Development of Deoxycorticosterone‐Saline Hypertension in Rats , 1975, Circulation research.
[20] E. Haber,et al. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. , 1969, The Journal of clinical endocrinology and metabolism.
[21] R. Mueller,et al. Turnover and synthesis of norepinephrine in experimental hypertension in rats. , 1969, Circulation research.
[22] A. Chobanian,et al. Body fluid and electrolyte composition in arterial hypertension. II. Studies in mineralocorticoid hypertension. , 1961, The Journal of clinical investigation.
[23] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[24] C. Hall,et al. Prevention of DOCA-salt hypertension with the calcium blocker nitrendipine. , 1983, Clinical and experimental hypertension. Part A, Theory and practice.
[25] W. Oelkers,et al. The effect of captopril on renin, angiotensin II, cortisol and aldosterone during ACTH-infusion in man. , 1982, Clinical and experimental hypertension. Part A, Theory and practice.
[26] M. Lokhandwala,et al. Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs. , 1982, Clinical and experimental hypertension. Part A, Theory and practice.
[27] A. J. Man in 't Veld,et al. Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes. , 1982, Clinical and experimental hypertension. Part A, Theory and practice.
[28] T. Philipp,et al. Studies on the mechanism of mineralocorticoid-induced blood pressure increase in man. , 1979, Clinical science.